BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30625254)

  • 1. Is there overuse of proton pump inhibitors in B-cell non-Hodgkin lymphomas? A cohort study based on the French health insurance database in the Midi-Pyrénées region.
    Conte C; Bourrel R; Despas F; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):327-338. PubMed ID: 30625254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals.
    Schepisi R; Fusco S; Sganga F; Falcone B; Vetrano DL; Abbatecola A; Corica F; Maggio M; Ruggiero C; Fabbietti P; Corsonello A; Onder G; Lattanzio F
    J Nutr Health Aging; 2016; 20(6):665-70. PubMed ID: 27273358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review.
    van Gestel LC; Adriaanse MA; Kanis SL; Mensink-Bout SM; Schoones JW; Numans ME; Kiefte-de Jong JC; van den Brink G
    BMC Prim Care; 2024 Jun; 25(1):208. PubMed ID: 38862886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of potentially inappropriate medications among newly treated patients with type 2 diabetes in UK primary care.
    Faquetti ML; Frey G; Stämpfli D; Weiler S; Burden AM
    Br J Clin Pharmacol; 2024 Jun; 90(6):1376-1394. PubMed ID: 38408767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of clinical pharmacists' recommendations on a proton pump inhibitor taper protocol in an ambulatory care practice.
    Bundeff AW; Zaiken K
    J Manag Care Pharm; 2013 May; 19(4):325-33. PubMed ID: 23627578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BEHIND THE PROTON PUMP INHIBITOR PRESCRIPTION: AN INTERNATIONAL SURVEY ON PHYSICIAN PRACTICES AND KNOWLEDGE.
    Piñerúa-Gonsálvez JF; Zambrano-Infantino RDC; Albornoz-Sandoval JC; Tong-Morao PW; León-Hernández MN; Matheus-Alonso BD; Suárez-López F; Flores Y; Higuera SN; Ruiz-Rebollo ML; Sulbaran M
    Arq Gastroenterol; 2024; 61():e23153. PubMed ID: 38451672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.
    Cahir C; Fahey T; Tilson L; Teljeur C; Bennett K
    BMC Health Serv Res; 2012 Nov; 12():408. PubMed ID: 23163956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Scope of Pre- and Probiotics as an Add-on to Proton-pump Inhibitors in Various Clinical Indications.
    Kalra S; Joshi A; Tiwaskar M; Agrawal N; Shaikh S; Bhatia BS; Jhingan AK; Rawal P; Das AK; Nishad SK; Manjrekar H; Bhadury S
    J Assoc Physicians India; 2023 Dec; 71(12):28-31. PubMed ID: 38736051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey.
    Kurlander JE; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Zikmund-Fisher BJ; Yang YX; Laine L; Weissman A; Saini SD
    Am J Gastroenterol; 2020 May; 115(5):689-696. PubMed ID: 32091419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate use of proton pump inhibitors in hospitalized patients with lower gastrointestinal bleeding.
    Quinn AJ; Saven H; Haile R; Moon SJ; Lee A; Thor S
    Hosp Pract (1995); 2024; 52(1-2):19-22. PubMed ID: 38407180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Appropriate Use of Proton Pump Inhibitors in Non-critically Ill Patients in Tertiary Medical Center: A Retrospective Study.
    Althagafi A; Magbool N; Altayib H; Bukhari T; Melibari N; Bahamdain F; Eljaaly K
    Curr Drug Saf; 2024 Feb; ():. PubMed ID: 38347790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of large scale, multicomponent intervention to reduce proton pump inhibitor overuse in integrated healthcare system: difference-in-difference study.
    Kurlander JE; Laine L; Kim HM; Roberts CB; Saffar D; Myers A; Holleman R; Gao Y; Shank M; Nelson R; Forman J; Helfrich CD; Krein SL; Saini SD; Yang YX
    BMJ; 2024 Apr; 385():e076484. PubMed ID: 38604668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events?
    Ben-Eltriki M; Chhabra M; Cassels A; Wright JM
    Curr Drug Saf; 2024; 19(2):244-247. PubMed ID: 37496243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton pump inhibitors and dementia risk: Evidence from a cohort study using linked routinely collected national health data in Wales, UK.
    Cooksey R; Kennedy J; Dennis MS; Escott-Price V; Lyons RA; Seaborne M; Brophy S
    PLoS One; 2020; 15(9):e0237676. PubMed ID: 32946449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship.
    Dutta AK; Jain A; Jearth V; Mahajan R; Panigrahi MK; Sharma V; Goenka MK; Kochhar R; Makharia G; Reddy DN; Kirubakaran R; Ahuja V; Berry N; Bhat N; Dutta U; Ghoshal UC; Jain A; Jalihal U; Jayanthi V; Kumar A; Nijhawan S; Poddar U; Ramesh GN; Singh SP; Zargar S; Bhatia S
    Indian J Gastroenterol; 2023 Oct; 42(5):601-628. PubMed ID: 37698821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study.
    Lin SH; Chang YS; Lin TM; Hu LF; Hou TY; Hsu HC; Shen YC; Kuo PI; Chen WS; Lin YC; Chen JH; Chang CC
    Front Immunol; 2021; 12():736036. PubMed ID: 34659225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate Prescribing of Proton Pump Inhibitors in Outpatient Clinics.
    Çelik F; Aypak C; Özdemir A; Görpelioğlu S
    Gastroenterol Nurs; 2021 Mar-Apr 01; 44(2):84-91. PubMed ID: 33795619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.